• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过光诱导的MHC I类抗原呈递纳米颗粒的配体交换将体内信使核糖核酸递送至病毒特异性T细胞。

In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles.

作者信息

Su Fang-Yi, Zhao Qingyang Henry, Dahotre Shreyas N, Gamboa Lena, Bawage Swapnil Subhash, Silva Trenkle Aaron D, Zamat Ali, Phuengkham Hathaichanok, Ahmed Rafi, Santangelo Philip J, Kwong Gabriel A

机构信息

The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.

Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30317, USA.

出版信息

Sci Adv. 2022 Feb 25;8(8):eabm7950. doi: 10.1126/sciadv.abm7950. Epub 2022 Feb 23.

DOI:10.1126/sciadv.abm7950
PMID:35196075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8865765/
Abstract

Simultaneous delivery of mRNA to multiple populations of antigen (Ag)-specific CD8 T cells is challenging given the diversity of peptide epitopes and polymorphism of class I major histocompatibility complexes (MHCI). We developed Ag-presenting nanoparticles (APNs) for mRNA delivery using pMHCI molecules that were refolded with photocleavable peptides to allow rapid ligand exchange by UV light and site-specifically conjugated with a lipid tail for postinsertion into preformed mRNA lipid nanoparticles. Across different TCR transgenic mouse models (P14, OT-1, and Pmel), UV-exchanged APNs bound and transfected their cognate Ag-specific CD8 T cells equivalent to APNs produced using conventionally refolded pMHCI molecules. In mice infected with PR8 influenza, multiplexed delivery of UV-exchanged APNs against three immunodominant epitopes led to ~50% transfection of a VHH mRNA reporter in cognate Ag-specific CD8 T cells. Our data show that UV-mediated peptide exchange can be used to rapidly produce APNs for mRNA delivery to multiple populations of Ag-specific T cells in vivo.

摘要

鉴于肽表位的多样性和I类主要组织相容性复合体(MHCI)的多态性,将信使核糖核酸(mRNA)同时递送至多个抗原(Ag)特异性CD8 T细胞群体具有挑战性。我们开发了用于mRNA递送的抗原呈递纳米颗粒(APN),其使用与光可裂解肽重折叠的pMHCI分子,以允许通过紫外线进行快速配体交换,并与脂质尾进行位点特异性缀合,以便在插入预先形成的mRNA脂质纳米颗粒后进行后插入。在不同的T细胞受体转基因小鼠模型(P14、OT-1和Pmel)中,紫外线交换的APN与使用传统重折叠的pMHCI分子产生的APN一样,能够结合并转染其同源Ag特异性CD8 T细胞。在感染PR8流感的小鼠中,针对三种免疫显性表位的紫外线交换APN的多重递送导致同源Ag特异性CD8 T细胞中约50%的VHH mRNA报告基因转染。我们的数据表明,紫外线介导的肽交换可用于快速生产APN,以便在体内将mRNA递送至多个Ag特异性T细胞群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/14a73e01304c/sciadv.abm7950-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/a3313bf86b36/sciadv.abm7950-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/dd777be94bce/sciadv.abm7950-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/15d57c13497b/sciadv.abm7950-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/d8c60c92908a/sciadv.abm7950-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/14a73e01304c/sciadv.abm7950-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/a3313bf86b36/sciadv.abm7950-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/dd777be94bce/sciadv.abm7950-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/15d57c13497b/sciadv.abm7950-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/d8c60c92908a/sciadv.abm7950-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddb0/8865765/14a73e01304c/sciadv.abm7950-f5.jpg

相似文献

1
In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles.通过光诱导的MHC I类抗原呈递纳米颗粒的配体交换将体内信使核糖核酸递送至病毒特异性T细胞。
Sci Adv. 2022 Feb 25;8(8):eabm7950. doi: 10.1126/sciadv.abm7950. Epub 2022 Feb 23.
2
Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface.抗CD8抗体可抑制或增强肽-主要组织相容性复合体I类(pMHCI)多聚体结合:这与其对细胞毒性T淋巴细胞(CTL)激活的影响相平行,且发生在细胞表面pMHCI与CD8之间不存在相互作用的情况下。
J Immunol. 2003 Dec 15;171(12):6650-60. doi: 10.4049/jimmunol.171.12.6650.
3
Peptide length determines the outcome of TCR/peptide-MHCI engagement.肽长度决定 TCR/肽-MHC I 结合的结果。
Blood. 2013 Feb 14;121(7):1112-23. doi: 10.1182/blood-2012-06-437202. Epub 2012 Dec 18.
4
An active CD8alpha/pMHCI interaction is required for CD8 single positive thymocyte differentiation.CD8α/pMHCⅠ 的相互作用对于 CD8 单阳性胸腺细胞的分化是必需的。
Eur J Immunol. 2010 Mar;40(3):836-48. doi: 10.1002/eji.200939663.
5
Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.共受体对 MHC 的亲和力决定了 TCR 与共刺激肽-MHC 相互作用的肽特异性要求。
J Exp Med. 2013 Aug 26;210(9):1807-21. doi: 10.1084/jem.20122528. Epub 2013 Aug 12.
6
Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells.在CD4+和CD8+ T细胞中表达对II类血凝素肽具有特异性的TCR受体的转基因小鼠中,参与抵抗流感病毒感染的细胞机制。
J Immunol. 1998 May 1;160(9):4500-7.
7
A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo.低亲和力TCR配体可在体内恢复CD8⁺T细胞的阳性选择。
J Immunol. 2001 Jun 1;166(11):6602-7. doi: 10.4049/jimmunol.166.11.6602.
8
T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding.T细胞受体与I类肽-主要组织相容性复合体的结合不会改变CD8的结合。
Mol Immunol. 2008 May;45(9):2700-9. doi: 10.1016/j.molimm.2007.12.009. Epub 2008 Feb 19.
9
Functional evidence for TCR-intrinsic specificity for MHCII.TCR对MHCII内在特异性的功能证据。
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3000-5. doi: 10.1073/pnas.1518499113. Epub 2016 Feb 1.
10
Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis.纳米颗粒介导的自身抗原肽靶向共递呈肝窦内皮细胞可预防 CD8 T 细胞驱动的自身免疫性胆管炎。
Immunology. 2021 Apr;162(4):452-463. doi: 10.1111/imm.13298. Epub 2021 Jan 7.

引用本文的文献

1
Bioinspired Extracellular Vesicles for Enhanced Delivery of siRNA to Tumors.用于增强小干扰RNA向肿瘤递送的仿生细胞外囊泡
Methods Mol Biol. 2025;2965:377-401. doi: 10.1007/978-1-0716-4742-4_19.
2
Eliciting antitumor immunity via therapeutic cancer vaccines.通过治疗性癌症疫苗激发抗肿瘤免疫力。
Cell Mol Immunol. 2025 Jul 9. doi: 10.1038/s41423-025-01316-4.
3
Nanoparticle Targeting Strategies for Lipid and Polymer-Based Gene Delivery to Immune Cells In Vivo.用于基于脂质和聚合物的基因体内递送至免疫细胞的纳米颗粒靶向策略

本文引用的文献

1
Synthetic Antigen-Presenting Cells for Adoptive T Cell Therapy.用于过继性T细胞疗法的合成抗原呈递细胞
Adv Ther (Weinh). 2021 Aug;4(8). doi: 10.1002/adtp.202100034. Epub 2021 Mar 18.
2
Functional HPV-specific PD-1 stem-like CD8 T cells in head and neck cancer.头颈部癌症中功能性 HPV 特异性 PD-1 干细胞样 CD8 T 细胞。
Nature. 2021 Sep;597(7875):279-284. doi: 10.1038/s41586-021-03862-z. Epub 2021 Sep 1.
3
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.工程化红细胞作为现成的异体抗肿瘤治疗剂。
Small Sci. 2024 Jul 30;4(9):2400248. doi: 10.1002/smsc.202400248. eCollection 2024 Sep.
4
Lipid nanoparticles for mRNA therapy: recent advances in targeted delivery.用于mRNA治疗的脂质纳米颗粒:靶向递送的最新进展
Life Med. 2022 Jun 24;1(1):21-23. doi: 10.1093/lifemedi/lnac004. eCollection 2022 Aug.
5
Bispecific antibody targeting of lipid nanoparticles.脂质纳米颗粒的双特异性抗体靶向作用。
bioRxiv. 2024 Dec 22:2024.12.20.629467. doi: 10.1101/2024.12.20.629467.
6
Nonviral targeted mRNA delivery: principles, progresses, and challenges.非病毒靶向mRNA递送:原理、进展与挑战。
MedComm (2020). 2025 Jan 2;6(1):e70035. doi: 10.1002/mco2.70035. eCollection 2025 Jan.
7
AND-gated protease-activated nanosensors for programmable detection of anti-tumour immunity.用于可编程检测抗肿瘤免疫的与门控蛋白酶激活纳米传感器。
Nat Nanotechnol. 2025 Mar;20(3):441-450. doi: 10.1038/s41565-024-01834-8. Epub 2025 Jan 3.
8
Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach.针对 RNA 治疗药物靶向递送而设计的脂质纳米粒的体内复杂旅程的探索:一种基于质量设计的方法。
J Nanobiotechnology. 2024 Nov 14;22(1):710. doi: 10.1186/s12951-024-02972-w.
9
Nanomaterial-based cancer immunotherapy: enhancing treatment strategies.基于纳米材料的癌症免疫疗法:增强治疗策略
Front Chem. 2024 Oct 10;12:1492215. doi: 10.3389/fchem.2024.1492215. eCollection 2024.
10
Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment.纳米技术在推进嵌合抗原受体T细胞疗法治疗癌症中的应用
Pharmaceutics. 2024 Sep 20;16(9):1228. doi: 10.3390/pharmaceutics16091228.
Nat Commun. 2021 May 11;12(1):2637. doi: 10.1038/s41467-021-22898-3.
4
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy.T 细胞基因编辑的递送技术:在癌症免疫治疗中的应用。
EBioMedicine. 2021 May;67:103354. doi: 10.1016/j.ebiom.2021.103354. Epub 2021 Apr 25.
5
Interfacing Biomaterials with Synthetic T Cell Immunity.生物材料与合成 T 细胞免疫的相互作用。
Adv Healthc Mater. 2021 Aug;10(15):e2100157. doi: 10.1002/adhm.202100157. Epub 2021 Apr 22.
6
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4 T cells.亲和力成熟的 HLA Ⅱ类二聚体可用于对抗原特异性 CD4 T 细胞进行强有力的染色。
Nat Biotechnol. 2021 Aug;39(8):958-967. doi: 10.1038/s41587-021-00836-4. Epub 2021 Mar 1.
7
T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design.靶向T细胞的纳米颗粒药物递送系统:合理设计的考量
ACS Nano. 2021 Mar 23;15(3):3736-3753. doi: 10.1021/acsnano.0c09514. Epub 2021 Feb 18.
8
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.新冠病例中SARS-CoV-2表位的T细胞免疫显性和免疫流行率的综合分析。
Cell Rep Med. 2021 Feb 16;2(2):100204. doi: 10.1016/j.xcrm.2021.100204. Epub 2021 Jan 26.
9
In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo.体外转录抗原受体 mRNA 纳米载体用于体内循环 T 细胞的瞬时表达。
Nat Commun. 2020 Nov 27;11(1):6080. doi: 10.1038/s41467-020-19486-2.
10
In vivo detection of antigen-specific CD8 T cells by immuno-positron emission tomography.免疫正电子发射断层扫描术检测抗原特异性 CD8 T 细胞。
Nat Methods. 2020 Oct;17(10):1025-1032. doi: 10.1038/s41592-020-0934-5. Epub 2020 Sep 14.